Professor Elizabeth Davis is a paediatric endocrinologist and Australian clinical researcher in paediatric diabetes. Professor Davis is the Head of the Department of Endocrinology and Diabetes at Perth Children’s Hospital - a state-wide service responsible for the care of all children with diabetes and endocrine disorders in Western Australia. In addition to her role as Clinical Professor at the University of Western Australia, Professor Davis co-directs the Children’s Diabetes Centre at The Kids Research Institute Australia, an integrated Clinical and Research Centre. She is interested in clinical research that improves the lives of children with diabetes.

A/Prof Sarah Glastras is a clinician researcher who is the Head of Department, and Senior Staff Specialist in Endocrinology at the Royal North Shore Hospital, Sydney and is an academic Associate Professor at the University of Sydney. She also consults at the Northern Sydney Endocrine Clinic. She undertakes basic science research in the area of type 1 diabetes and weight loss, and she is a principal researcher in a major NHMRC funded population-based project in gestational diabetes and pregnancy outcomes. She runs many clinical studies in the areas of diabetes, obesity, and hypertriglyceridaema, including type 1 diabetes prevention.

A/Prof. Tony Huynh is the Director of Endocrinology and Diabetes at the Queensland Children’s Hospital, a Chemical Pathologist at Mater Pathology in Brisbane, and an Associate Professor in the Child Health Research Centre within the Faculty of Health, Medicine and Behavioural Sciences at the University of Queensland. He completed his PhD at the Children’s National Hospital in Washington DC investigating glucocorticoid receptor signalling in dystrophic muscle. He is president-elect of the Australia and New Zealand Society of Paediatric Endocrinology and Diabetes (ANZSPED), co-chair of the ANZSPED Laboratory and Newborn Screening Subcommittee, and a member of the ANZSPED Diabetes Subcommittee. His interests include neonatal endocrinology, T1D immunity, and laboratory medicine.

Prof John Wentworth is an endocrinologist at Royal Melbourne Hospital and research fellow at St Vincent’s Institute of Medical Research. He runs the only laboratory in the Southern Hemisphere capable of running islet autoantibody assays that predict clinical disease. He set up the Type1Screen program for T1D families in 2019 and is lead clinical trial investigator for the Australasian T1D Immunotherapy Collaborative (ATIC). In these roles he is working with colleagues to strengthen the case for universal T1D screening that enables timely access to disease-modifying therapies.